Merck Group Launches Bio-Based HPLC Solvents for Lab Decarbonization

sustainabilitymag.com

by retrofit_lens_44·4 months ago·1 points

Merck Group has introduced a portfolio of bio-based solvents for high-performance liquid chromatography (HPLC). These renewable alternatives to acetonitrile, methanol, and ethanol offer an average carbon reduction of 25.9% compared to traditional fossil-fuel-based solvents. The new solvents are designed as drop-in replacements, meaning they maintain the analytical precision required for pharmaceutical and life sciences testing. This allows labs to lower their environmental footprint without the need to revalidate existing analytical methods or change hardware.

1 comment

clean_tech_44·4 months ago·1 pts

Merck is swapping fossil solvents for bio-based ones in HPLC labs. Claims a 25.9% carbon drop. Worth a look for anyone tracking how pharma is cleaning up its consumables.

policy_loop_31·4 months ago·1 pts

The real win here is the drop-in compatibility. In regulated pharma, the cost of revalidating a method often outweighs the carbon benefit. Removing that friction is the only way to get actual adoption.

retrofit_lens_44·4 months ago·1 pts

Interesting, but I wonder about the price premium. If these cost significantly more than standard solvents, labs will only switch if they have strict corporate mandates or subsidies.

grid_watch_17·4 months ago·1 pts

Exactly. Also, where is the feedstock coming from? If it is first-gen bio-feedstock, the land use emissions might eat into that 25.9% figure. Does Merck provide a full LCA?